AORT logo

Artivion Inc. (AORT)$22.46

Market Cap: 1.01 BCurrency: USD

Research Snapshot

Static fundamentals, valuation context, and investor signals for Artivion Inc. (AORT).

HEALTHCARE
MEDICAL DEVICES
DCF ready

Valuation

1388.5x

EV/FCF, 0.1% FCF yield

Quality

1.5%

ROIC, 0.2% FCF margin

Growth

11.8%

5Y sales (revenue) CAGR

Balance sheet

0.5x

Debt/equity, 3.5x current ratio

Superinvestors

1

Top: First Eagle Investment Management (0.0%)

Strengths to research

  • Revenue compounded at 11.8% over five years.
  • Debt/equity looks manageable at 0.5x.
  • 10 annual periods are available for trend analysis.

Watchouts

  • P/E is elevated at 107.0x.
  • P/FCF is elevated at 1209.4x.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026

Quality Scorecard

Build-time composite score for AORT.

Grade D
28
/ 100

Peer Comparison

Target stock against 8 market-cap comparable peers.

Heat map: red worst to green best
AORT
Target
Artivion Inc.$1.0B107.0x1388.5x1.5%11.8%0.2%64.4%2.7xN/A
IARTIntegra LifeSciences Holdings$1.0B-2.2x-48.9x-29.2%3.6%-1.9%N/AN/AN/A
AHCOAdaptHealth Corp.$1.2B-20.1x12.8x-2.2%25.2%6.8%N/A3.4xN/A
INMDInMode Ltd.$868.1M9.6x6.7x13.7%12.4%22.7%78.5%-3.5xN/A
QDELQuidelOrtho Corp.$1.9B-0.7x-53.0x-24.5%10.4%-3.0%N/AN/AN/A
ENOVEnovis Corp.$2.0B-1.2x161.2x-42.5%14.9%0.9%59.8%5.7xN/A
LIVNLivaNova PLC$2.0B-16.6x9.9x-15.4%8.2%12.5%67.7%-1.1xN/A
LABStandard Biotools Inc$435.8M-5.1x-3.8x-17.7%-9.2%-96.9%49.9%N/AN/A
ITGRInteger Holdings Corp.$4.1B30.9x49.8x3.5%11.5%5.7%27.0%3.3xN/A

Financial Charts

No financial data available for AORT (annual).

1 superinvestors own AORT

Current quarter ownership and quarter-over-quarter share changes.

Superinvestor ownership
FundSharesValue% PortfolioQoQ Change
First Eagle Investment Management

First Eagle Investment Management

311,601$11M0.02%0.0%